Alcohol Research in HIV: Relapse Prevention

Recruiting now · Not applicable

Conditions studied: HIV, Alcohol Use Disorder

In brief

3-arm type 1 pilot implementation-efficacy trial for people with alcohol use disorders to examine the preliminary effectiveness and feasibility of an adapted 2-session, computerized and person delivered relapse prevention intervention.

Key facts

Study ID

NCT05163301

Run by

Johns Hopkins University

People needed

150

Starts

2023-03-27

Expected to finish

2027-05-31

Last updated by the study team

2026-02-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed diagnosis of HIV
• Aged 18 years or older
• Must be enrolled in clinical care at Johns Hopkins HIV Clinic.
• In addition, meet the following alcohol use criteria:
• lifetime alcohol use disorder
• patient reported outcomes (PRO) assessment collected by the Center for AIDS Research (CFAR) Network of Clinical Systems as part of usual clinical care that show in the last 3 years: periods of no or lower risk drinking (e.g. women/men who are drinking <11/22 drinks per week) and periods of lapse to higher levels of drinking (=>11/22 drinks per week for women/men)
• current PRO showing alcohol abstinence or alcohol use at <11/22 drinks per week for women/men.

You may not qualify if…

• Acutely suicidal, homicidal, psychotic or otherwise unable to provide informed consent
• Non-English speaking because interventions are currently available in English only

Where it is running

• Johns Hopkins School of Medicine — Baltimore, Maryland, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.